Название продукции:(S)-4-(tert-Butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid

IUPAC Name:(2S)-4-[(tert-butoxy)carbonyl]-1,4-oxazepane-2-carboxylic acid

CAS:1273567-44-4
Молекулярная формула:C11H19NO5
Чистота:95%
Номер в каталоге:CM284795
Молекулярная масса:245.28

Упаковочная единица Доступно для заказа Цена ($) Количество
CM284795-1g in stock ħħŌ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1273567-44-4
Молекулярная формула:C11H19NO5
Точка плавления:-
Smiles-код:O=C([C@H]1OCCCN(C(OC(C)(C)C)=O)C1)O
Плотность:
Номер в каталоге:CM284795
Молекулярная масса:245.28
Точка кипения:384.0±42.0°C at 760 mmHg
Номер Mdl:MFCD19442252
Хранение:Store at 2-8°C.

Column Infos

Brensocatib
May 28 2024, Insmed announced positive topline results from landmark ASPEN study of Brensocatib in patients with bronchiectasis.
Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1) being developed for the treatment of patients with bronchiectasis, CRSsNP, and other neutrophil-mediated diseases. DPP1 is an enzyme responsible for activating neutrophil serine proteases (NSPs), such as neutrophil elastase, in neutrophils when they are formed in the bone marrow. Brensocatib is an investigational drug product that has not been approved for any indication in any jurisdiction.

Related Products